October 09, 2025

How Fibrosis Disrupts the Heart’s Electrical Signals

How Fibrosis Disrupts the Heart’s Electrical Signals

Innovative imaging technique reveals hidden electrical connections in diseased hearts and provides new therapeutic approaches

Cardiac fibrosis can be life-threatening: the formation of connective tissue in the heart muscle causes it to become stiffer, impairs electrical signal transmission, and weakens pumping capacity, which can lead to cardiac arrhythmias. However, the effects of cardiac fibrosis on the electrical conductivity of the heart have been insufficiently studied to date. A research team led by the University of Freiburg, with the participation of the Karlsruhe Institute of Technology (KIT), has now closed this gap, gaining new insights into the fundamentals of electrophysiology in cardiac fibrosis and thus opening up further possibilities for personalized diagnostic and therapeutic approaches.

Computer models and digital twins

Using optical imaging and 3D computer models of mouse hearts, the researchers found that fibrotic tissue acts as a “low-pass filter” for electrical activation of the heart, the electrophysiology: The slowed or blocked transmission of electrical impulses at a higher pulse rate, for example due to physical exertion, can lead to dangerous cardiac arrhythmias – as is the case with arrhythmogenic cardiomyopathy, which occurs particularly in young people. Targeted stress tests are therefore important for the diagnosis of high-risk patients.

“For the first time, we were able to decipher the influence of connective tissue, interacting with the muscle cells of the heart, in arrhythmogenic cardiomyopathy”, explains Dr. Francesco Giardini from the University of Freiburg. The “Computer Models of the Heart” research group led by Dr.Axel Loewe from KIT has integrated the experimental data in computer simulations and developed a digital twin of the biological experiment, showing the disrupted propagation of excitation at higher heart rates. “We want to extend the method to larger animal models and models of the human heart in order to further develop digital twins for precision cardiology and thus improve clinical diagnostics and treatment,” says Loewe.

lkr, October 7, 2025

Our latest News

discover more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp